The Summary
In a randomized, double-blind, placebo-controlled trial, researchers evaluated a 12-week multi-strain probiotic supplement in 61 Parkinson's disease patients with clinically significant anxiety. While both the probiotic and placebo groups showed similar improvements in anxiety levels, the probiotic group experienced a statistically significant boost in cognitive function, scoring 1.1 points higher on the Montreal Cognitive Assessment than the placebo group. No other changes were noted in depression, motor symptoms, constipation, inflammation, or gut microbiota composition, suggesting that while probiotics did not target anxiety, they may support brain health.
Why this is interesting
The gut-brain axis is a major focus in Parkinson's research, and while scientists hoped probiotics would ease anxiety, the real surprise was the cognitive improvement. A 1.1-point increase on a cognitive test is a promising signal for a disease where mental decline is a major concern. For readers, this suggests that targeting gut health might not be a quick fix for mood, but could play a vital role in protecting memory and thinking skills. It highlights the complex connection between our gut microbiome and brain health, warranting further study.